Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $65.40 USD
Change Today +1.39 / 2.17%
Volume 580.4K
As of 8:10 PM 06/1/15 All times are local (Market data is delayed by at least 15 minutes).

cyberonics inc (CYBX) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/26/15 - $76.48
52 Week Low
11/20/14 - $48.19
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CYBERONICS INC (CYBX)

cyberonics inc (CYBX) Related Bloomberg News

View More Bloomberg News

cyberonics inc (CYBX) Related Businessweek News

No Related Businessweek News Found

cyberonics inc (CYBX) Details

Cyberonics, Inc., together with its subsidiaries, designs, develops, markets, and sells implantable medical devices to hospitals and ambulatory surgery centers. The company offers vagus nerve stimulation (VNS) therapy system that uses pulsed electrical signals applied to the vagus nerve for the treatment of refractory epilepsy and treatment-resistant depression. It is also engaged in investigating the use of VNS and other neuromodulation therapy for other indications, including chronic heart failure, and developing non-implantable device solutions for the management of epilepsy. The company sells its products directly, as well as through independent distributors in Europe, Canada, Mexico, Australia, parts of Central and South America, the Middle East, China, Japan, and other parts of Asia. Cyberonics, Inc. was founded in 1987 and is headquartered in Houston, Texas.

639 Employees
Last Reported Date: 06/16/14
Founded in 1987

cyberonics inc (CYBX) Top Compensated Officers

Chief Executive Officer, President and Execut...
Total Annual Compensation: $613.7K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $334.1K
Chief Operating Officer and Senior Vice Presi...
Total Annual Compensation: $186.6K
Chief Administrative Officer, Senior Vice Pre...
Total Annual Compensation: $318.1K
Vice President of Emerging Therapy
Total Annual Compensation: $100.4K
Compensation as of Fiscal Year 2014.

cyberonics inc (CYBX) Key Developments

Sorin and Cyberonics Announce Executive Leadership Team for the New Company Upon Close of Merger

Sorin S.p. A and Cyberonics Inc. announced the executive leadership team for the new company effective at the close of the proposed merger. André-Michel Ballester, Sorin’s Chief Executive Officer, will serve as the new company’s Chief Executive Officer, and Dan Moore, Cyberonics’ Chief Executive Officer, will be the non-executive Chairman. The new company will be organized into three business units and an Intercontinental group, with the following leaders: Michel Darnaud, Sorin’s President, Cardiac Surgery, will lead the Cardiac Surgery business unit. Stefano Di Lullo, Sorin’s President, Cardiac Rhythm Management, will lead the Cardiac Rhythm Management business unit. Rohan Hoare, Cyberonics’ Chief Operating Officer, will lead the Neuromodulation business unit. Jacques Gutedel, Sorin’s Vice President, Intercontinental, will head the Intercontinental group. The new company’s Executive Leadership Team will also include the following functional leaders: Ed Andrle, Sorin’s Vice President, Strategy & Business Development, will manage Strategy, Business Development and New Ventures /Emerging Therapies. Brian Sheridan, Sorin’s General Counsel, will serve as General Counsel for the combined organization. Pritpal Shinmar, Sorin’s Vice President, Market Access, will be responsible for the Global Market Access function. David Wise, Cyberonics’ Chief Administrative Officer, will lead the Human Resources and the Information Technology functions. Sorin and Cyberonics have initiated a search for the Chief Financial Officer position of the combined company and expect to name the selected candidate before closing. Greg Browne, Cyberonics’ Chief Financial Officer, will serve as interim Chief Financial Officer for the new company, should the position not be filled prior to closing, and plans to retire in 2016. Demetrio Mauro, Sorin’s Chief Financial Officer, will lead the overall integration as Chief Integration Officer to ensure the new company is fully operational on day one following closing. The role also calls for significant planning for the post-closing period, including achievement of previously announced synergies. Until the closing of the transaction, the respective companies will continue to operate under current leadership structures and as two separate companies. As previously announced, the transaction is expected to be completed by the end of the third calendar quarter of 2015 and is subject to approval by both Sorin and Cyberonics shareholders, the receipt of required regulatory clearances, and other customary closing conditions.

Sorin S.p.A. and Cyberonics Inc. Announce Formation of New Company

Sorin S.p.A. and Cyberonics Inc. announced the Executive Leadership Team for the new company effective at the close of the proposed merger. The new company will be organized into three business units and an Intercontinental group.

Cyberonics Inc. Presents at 10th Annual Neurotech Investing & Partnering Conference, Apr-08-2015 09:00 AM

Cyberonics Inc. Presents at 10th Annual Neurotech Investing & Partnering Conference, Apr-08-2015 09:00 AM. Venue: Hotel Nikko, 222 Mason Street, San Francisco, California, United States. Speakers: Sherrie L. Perkins, Vice President of Marketing & New Business Development.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CYBX:US $65.40 USD +1.39

CYBX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AngioDynamics Inc $16.11 USD +0.06
ICU Medical Inc $98.36 USD +1.36
Masimo Corp $35.53 USD +0.43
RTI Surgical Inc $6.56 USD +0.09
Wright Medical Group Inc $27.51 USD +0.11
View Industry Companies

Industry Analysis


Industry Average

Valuation CYBX Industry Range
Price/Earnings 26.1x
Price/Sales 5.8x
Price/Book 6.2x
Price/Cash Flow 25.3x
TEV/Sales 5.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CYBERONICS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at